GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | Tamoxifen | FACs and SFA followed by Western Blotting and RT-PCR | NA | 0.6 | 1 | 29602199
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by FACs and qRT-PCR | NA | 0.6 | 1 | 31300015
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | Western Blotting and SFA | NA | 0.6 | 1 | 31497349
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | IF staining followed by SFA | NA | 0.6 | 1 | 31591823
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | FACs | NA | 0.6 | 1 | 34315857
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | FACs followed by CFA | NA | 0.6 | 1 | 35235236
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | Doxorubicin | FACs followed by SFA | NA | 0.6 | 1 | 33221681
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | Carboplatin | FACs followed by SFA | NA | 0.6 | 1 | 33221681
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | Paclitaxel | FACs followed by SFA | NA | 0.6 | 1 | 33221681
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | FACs followed by SFA | NA | 0.6 | 1 | 34944852
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by FACs | NA | 0.6 | 1 | 33144693
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | 5-Fluorouracil | FACs | NA | 0.6 | 1 | 29371950
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | FACs | NA | 0.6 | 1 | 30076320
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | Medrooxyprogesterone Acetate | FACs followed by SFA | NA | 0.6 | 1 | 28744156
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | FACs followed by SFA | NA | 0.6 | 1 | 29048610
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | FACs followed by SFA | NA | 0.6 | 1 | 30326469
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | FACs followed by SFA | NA | 0.6 | 1 | 31599500
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | FACs followed by SFA | NA | 0.6 | 1 | 31736268
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | Paclitaxel | FACs followed by SP assay and SFA | NA | 0.6 | 1 | 30361903
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | Tamoxifen | SFA followed by FACs | NA | 0.6 | 1 | 29363524
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by FACs | NA | 0.6 | 1 | 31619923
|
CD44 | 1681 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by FACs and Tumorigenicity assay | NA | 0.6 | 1 | 28938607
|
CXCR4 | 2561 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.48 | 0.0498 | 19353633
|
ACBD3 | 15453 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | RT-PCR and Western Blotting followed by SP assay and SFA | NA | 0.48 | 0.0032 | 29307786
|
BAG3 | 939 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.0021 | 28703799
|
CCND1 | 1582 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.0201 | 31595560
|
CXCR4 | 2561 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.0498 | 28703799
|
KLF4 | 6348 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | qRT-PCR and Western Blotting followed by SFA | NA | 0.48 | 0.0891 | 30326469
|
KLF4 | 6348 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.0891 | 31595560
|
KLF4 | 6348 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by RT-PCR and IHC staining | NA | 0.48 | 0.0891 | 30131941
|
MYC | 7553 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | qRT-PCR and Western Blotting followed by SFA | NA | 0.48 | 0.1304 | 30326469
|
MYC | 7553 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | qRT-PCR followed by Western Blotting and SFA | NA | 0.48 | 0.1304 | 31736268
|
MYC | 7553 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | Tamoxifen | Western Blotting and RT-PCR | NA | 0.48 | 0.1304 | 29602199
|
MYC | 7553 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by RT-PCR and IHC staining | NA | 0.48 | 0.1304 | 30131941
|
NANOG | 20857 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | qRT-PCR and Western Blotting followed by CFA | NA | 0.48 | 0.5461 | 35235236
|
NANOG | 20857 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | qRT-PCR followed by Western Blotting and SFA | NA | 0.48 | 0.5461 | 31736268
|
NANOG | 20857 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5461 | 31300015
|
NANOG | 20857 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.5461 | 28703799
|
NANOG | 20857 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | Tamoxifen | Western Blotting and RT-PCR | NA | 0.48 | 0.5461 | 29602199
|
NANOG | 20857 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by RT-PCR and IHC staining | NA | 0.48 | 0.5461 | 30131941
|
NANOG | 20857 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Western Blotting | NA | 0.48 | 0.5461 | 28802057
|
POU5F1 | 9221 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | qRT-PCR and Western Blotting followed by CFA | NA | 0.48 | 0.6448 | 35235236
|
POU5F1 | 9221 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | qRT-PCR and Western Blotting followed by SFA | NA | 0.48 | 0.6448 | 30326469
|
POU5F1 | 9221 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | qRT-PCR followed by Western Blotting and SFA | NA | 0.48 | 0.6448 | 31736268
|
POU5F1 | 9221 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 31300015
|
POU5F1 | 9221 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | Western Blotting and SFA | NA | 0.48 | 0.6448 | 34362383
|
POU5F1 | 9221 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 28802057
|
POU5F1 | 9221 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | Tamoxifen | Western Blotting | NA | 0.48 | 0.6448 | 29602199
|
PROM1 | 9454 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.7582 | 31595560
|
PROM1 | 9454 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | Cisplatin | IF staining followed by SFA | NA | 0.48 | 0.7582 | 31595560
|
PROM1 | 9454 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by IF staining | NA | 0.48 | 0.7582 | 28935760
|
SOX2 | 11195 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | qRT-PCR and Western Blotting followed by CFA | NA | 0.48 | 0.5695 | 35235236
|
SOX2 | 11195 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | qRT-PCR and Western Blotting followed by SFA | NA | 0.48 | 0.5695 | 30326469
|
SOX2 | 11195 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | qRT-PCR followed by Western Blotting and SFA | NA | 0.48 | 0.5695 | 31736268
|
SOX2 | 11195 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5695 | 31300015
|
SOX2 | 11195 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by RT-PCR and Western Blotting | NA | 0.48 | 0.5695 | 28703799
|
SOX2 | 11195 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by RT-PCR and IHC staining | NA | 0.48 | 0.5695 | 30131941
|
SOX2 | 11195 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | Western Blotting and SFA | NA | 0.48 | 0.5695 | 34362383
|
SOX2 | 11195 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Western Blotting | NA | 0.48 | 0.5695 | 28802057
|
WNT1 | 12774 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.0074 | 31595560
|
PGR | 8910 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by qRT-PCR and IHC staining | Down | 0.44 | 0.0021 | 19353633
|
ALDH1A1 | 402 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by ALDEFLUOR assay and Western Blotting | NA | 0.4 | 0.684 | 31497349
|
ALDH1A1 | 402 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by ALDEFLUOR assay and IF staining | NA | 0.4 | 0.684 | 28935760
|
ALDH1A1 | 402 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by ALDEFLUOR assay and RT-PCR | NA | 0.4 | 0.684 | 30131941
|
ALDH1A1 | 402 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | IF staining followed by SFA | NA | 0.4 | 0.684 | 31591823
|
ALDH1A1 | 402 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | IF staining followed by SFA | NA | 0.4 | 0.684 | 31595560
|
ALDH1A1 | 402 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | ALDEFLUOR assay | NA | 0.4 | 0.684 | 34315857
|
ALDH1A1 | 402 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | ALDEFLUOR assay followed by SFA | NA | 0.4 | 0.684 | 34944852
|
ALDH1A1 | 402 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by ALDEFLUOR assay | NA | 0.4 | 0.684 | 33144693
|
ALDH1A1 | 402 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | ALDEFLUOR assay followed by SFA | NA | 0.4 | 0.684 | 28802057
|
ALDH1A1 | 402 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | Tamoxifen | FACs followed by SFA | NA | 0.4 | 0.684 | 29602199
|
CD24 | 1645 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by FACs and qRT-PCR | NA | 0.32 | 0.456 | 31300015
|
CD24 | 1645 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | 5-Fluorouracil | FACs | NA | 0.32 | 0.456 | 29371950
|
CD24 | 1645 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | FACs | NA | 0.32 | 0.456 | 30076320
|
CD24 | 1645 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | Tamoxifen | FACs followed by SFA | NA | 0.32 | 0.456 | 29602199
|
CD24 | 1645 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | FACs followed by SFA | NA | 0.32 | 0.456 | 30326469
|
CD24 | 1645 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | FACs followed by SFA | NA | 0.32 | 0.456 | 31599500
|
CD24 | 1645 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | FACs followed by SFA | NA | 0.32 | 0.456 | 31736268
|
CD24 | 1645 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | Paclitaxel | FACs followed by SP assay and SFA | NA | 0.32 | 0.456 | 30361903
|
CD24 | 1645 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by FACs | NA | 0.32 | 0.456 | 31619923
|
CD24 | 1645 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by FACs and Tumorigenicity assay | NA | 0.32 | 0.456 | 28938607
|
LUCAT1 | 48498 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by qRT-PCR and FACs | NA | 0.32 | 0.0021 | 31300015
|
ABCG2 | 74 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1739 | 28935760
|
CD24 | 1645 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | Western Blotting and SFA | NA | 0.28 | 0.456 | 31497349
|
CD24 | 1645 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | FACs | NA | 0.28 | 0.456 | 34315857
|
CD24 | 1645 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | FACs followed by CFA | NA | 0.28 | 0.456 | 35235236
|
CD24 | 1645 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | FACs followed by SFA | NA | 0.28 | 0.456 | 34944852
|
CD24 | 1645 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by FACs | NA | 0.28 | 0.456 | 33144693
|
CTNNB1 | 2514 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | Tamoxifen | Western Blotting | NA | 0.28 | 0.0647 | 29602199
|
DDX27 | 15837 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0011 | 34362383
|
RELA | 9955 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0032 | 31497349
|
SOX9 | 11204 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | Tamoxifen | Western Blotting followed by SFA | NA | 0.28 | 0.0244 | 31690832
|
STAT3 | 11364 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0223 | 31619923
|
NOTCH1 | 7881 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | IF staining followed by SFA | NA | 0.24 | 0.0477 | 31595560
|
NUMB | 8060 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | IF staining followed by SFA | NA | 0.24 | 0.0021 | 31595560
|
ESR1 | 3467 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0042 | 19353633
|
TNFSF13 | 11928 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | RT-PCR followed by SFA | NA | 0.2 | 0.0021 | 30131941
|
TNFSF13B | 11929 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | RT-PCR followed by SFA | NA | 0.2 | 0.0011 | 30131941
|
CXCR3 | 4540 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by FACs | NA | 0.12 | 0.0011 | 31619923
|
LIN28A | 15986 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by FACs and Tumorigenicity assay | NA | 0.12 | 0.0138 | 28938607
|
MST1 | 7380 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by FACs and Tumorigenicity assay | NA | 0.12 | 0.0032 | 28938607
|
MST1R | 7381 | LTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by FACs and Tumorigenicity assay | NA | 0.12 | 0.0032 | 28938607
|
ACSL1 | 3569 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 19353633
|
ACSL3 | 3570 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 19353633
|
AQP3 | 636 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 19353633
|
ARFGEF1 | 15772 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
ATP9A | 13540 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 19353633
|
ATP9B | 13541 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
AURKB8 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
BEND6 | 20871 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
BIRC51 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
BPIFB1 | 16108 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 19353633
|
BRD9 | 25818 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
C17ORF63 | 25563 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
C1ORF54 | 26258 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 19353633
|
CADPS2 | 16018 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 19353633
|
CCDC71 | 25760 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 19353633
|
CCNB1 | 1579 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 19353633
|
CDC208 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
CDC25C7 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
CDCA3 | 14624 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
CDCA47 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
CENPA2 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
CENPL | 17879 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
CENPM | 18352 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
CGNL1 | 25931 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 19353633
|
CKS1B | 19083 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
CLCA2 | 2016 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 19353633
|
CLCN3 | 2021 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 19353633
|
CPA3 | 2298 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
CPD | 2301 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
CSN2 | 2447 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
CSN3 | 2446 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
CXCL119 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
CXCL1210 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
CYP1A1 | 2595 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 19353633
|
CYP4Z2P | 24426 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
DDIT3 | 2726 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 19353633
|
DENND1B | 28404 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 19353633
|
DJ434O11 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
DMACs2L | 18799 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 19353633
|
DNAJC10 | 24637 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 19353633
|
DNAJC12 | 28908 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 19353633
|
DSCR1 | 3040 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
DSP | 3052 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 19353633
|
DUSP6 | 3072 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 19353633
|
ECHDC3 | 23489 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 19353633
|
EEF1A23 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
EHD1 | 3242 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 19353633
|
ERICH1 | 27234 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 19353633
|
ESF1 | 15898 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 19353633
|
FAM49B | 25216 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 19353633
|
FAM83D | 16122 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
FKBP5 | 3721 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 19353633
|
FLJ25865 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
FOXM17 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
FOXP110 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
GADD45G9 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
GALNT79 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
GDF159 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
GJA1 | 4274 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 19353633
|
GJB1 | 4283 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 19353633
|
GOLGA4 | 4427 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
GPNMB6 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
GSTA2 | 4627 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
GTSE13 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
GYMAP7 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
H195 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
H4C14 | 4794 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 19353633
|
HBP110 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
HDAC9 | 14065 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 19353633
|
HEATR5A | 20276 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 19353633
|
HIVEP1 | 4920 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
HK1 | 4922 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 19353633
|
HOOK1 | 19884 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 19353633
|
HROB | 28460 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
HSD17B14 | 23238 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
ID1 | 5360 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 19353633
|
ID35 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
IGFBP46 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
IGFBP52 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
ITGAE | 6147 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
KAT6B | 17582 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
KCNK59 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
KLHL13 | 22931 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 19353633
|
LGALS1 | 6561 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 19353633
|
LINC00905 | 26334 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
LMO7 | 6646 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 19353633
|
LRRC61 | 21704 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 19353633
|
MAN2A110 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
MAP4K3 | 6865 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
MCM59 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
MSMB | 7372 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
MVP | 7531 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 19353633
|
MYBL21 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
MYO9A | 7608 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 19353633
|
NAGS | 17996 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
NCAPH | 1112 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
NDRG19 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
NEDD4 | 7727 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 19353633
|
NEDD4L | 7728 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
NETO1 | 13823 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
NIBAN1 | 16784 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 19353633
|
NME1 | 7849 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
NUCB2 | 8044 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 19353633
|
ODC19 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
OIP58 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
ORC6L2 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
PAGM5 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
PER3 | 8847 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
PIK3C3 | 8974 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
PIMREG | 25483 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
PIP | 8993 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 19353633
|
PLA2G4C | 9037 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 19353633
|
PLK13 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
PNPLA10P | 32928 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
POU4F2 | 9219 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
PREX1 | 32594 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 19353633
|
PRRC2B | 28121 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
PSCA | 9500 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 19353633
|
PTGR1 | 18429 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 19353633
|
PTPLA9 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
RAB27B | 9767 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 19353633
|
RAD51 | 9817 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 19353633
|
RFC2 | 9970 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
RPS6KA5 | 10434 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 19353633
|
RRAGD | 19903 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 19353633
|
RSF1 | 18118 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 19353633
|
S100P | 10504 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0106 | 19353633
|
SAT1 | 10540 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 19353633
|
SCGB1D29 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
SCGB2A1 | 7051 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
SERINC1 | 13464 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
SFRS1810 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
SH3BGRL4 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
SLC12A2 | 10911 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 19353633
|
SLC25A2 | 22921 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
STEAP1 | 11378 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 19353633
|
SUSD3 | 28391 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 19353633
|
SYTL2 | 15585 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 19353633
|
TAOK3 | 18133 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 19353633
|
TBC1D15 | 25694 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 19353633
|
TCF7L1 | 11640 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 19353633
|
TK19 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
TMEM132D | 29411 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
TMEM489 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
TMEM87A | 24522 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 19353633
|
TMEM98 | 24529 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 19353633
|
TMPO8 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
TPD52L110 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
TRIP138 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
TROAP8 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
TUBA1B | 18809 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 19353633
|
TUT7 | 25817 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
TXNDC16 | 19965 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 19353633
|
UBE2C7 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
UBE2S8 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
UBE2T7 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
UMPK9 | NA | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 19353633
|
USP34 | 20066 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
VLDLR | 12698 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
VSIG2 | 17149 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
WASF1 | 12732 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 19353633
|
ZC3H13 | 20368 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 19353633
|
ZFHX3 | 777 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 19353633
|
ZNF222 | 13015 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 19353633
|
ZNF638 | 17894 | HTM | Luminal A Breast Cancer | Ductal Carcinoma | T47D | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 19353633
|